Reduced phosphorylation of DNA PKcs T2609 in pMU- or pMC- treated glioma cells further strengthens these results and the earlier reported findings, wherein, decreased DNA end processing of DSBs was observed by inhibition of DNA PKcs T2609 phosphorylation [31]. Here, PRKDC is linked to central nervous system cancer.